Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Analyst says sell Abbott after stock 'overreacted' to COVID-19 opportunity » 13:26
06/01/20
06/01
13:26
06/01/20
13:26
ABT

Abbott

$93.06 /

-2.25 (-2.36%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, HSIC

Henry Schein

$61.21 /

+0.48 (+0.79%)

, SIEGY

Siemens

$0.00 /

+ (+0.00%)

Shares of Abbott…

Open Full Text

ShowHide Related Items >><<
SIEGY Siemens
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

HSIC Henry Schein
$61.21 /

+0.48 (+0.79%)

ABT Abbott
$93.06 /

-2.25 (-2.36%)

ABT Abbott
$93.06 /

-2.25 (-2.36%)

06/01/20
Fly Intel: Top five analyst downgrades
05/31/20 Goldman Sachs
Abbott downgraded to Sell from Neutral at Goldman Sachs
04/20/20 Barclays
Abbott price target raised to $100 from $92 at Barclays
04/20/20 Barclays
Abbott price target raised to $100 from $92 at Barclays
RHHBY Roche
$0.00 /

+ (+0.00%)

05/15/20 Barclays
Roche price target raised to CHF 395 from CHF 385 at Barclays
05/14/20 Mizuho
Arcus Biosciences price target raised to $40 from $22 at Mizuho
05/13/20 Wolfe Research
Roche upgraded to Outperform from Peer Perform at Wolfe Research
05/13/20 Wolfe Research
Roche upgraded to Outperform from Peer Perform at Wolfe Research
HSIC Henry Schein
$61.21 /

+0.48 (+0.79%)

05/06/20 Barrington
Henry Schein downgraded to Market Perform from Outperform at Barrington
04/07/20 Goldman Sachs
Henry Schein upgraded to Buy from Neutral at Goldman Sachs
04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
SIEGY Siemens
$0.00 /

+ (+0.00%)

05/28/20 Deutsche Bank
Siemens price target raised to EUR 115 from EUR 110 at Deutsche Bank
05/14/20 Societe Generale
Siemens price target raised to EUR 105 from EUR 95 at Societe Generale
05/11/20 JPMorgan
Siemens price target raised to EUR 104 from EUR 90 at JPMorgan
04/09/20 Deutsche Bank
Siemens price target lowered to EUR 100 from EUR 105 at Deutsche Bank
RHHBY Roche
$0.00 /

+ (+0.00%)

HSIC Henry Schein
$61.21 /

+0.48 (+0.79%)

ABT Abbott
$93.06 /

-2.25 (-2.36%)

SIEGY Siemens
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

ABT Abbott
$93.06 /

-2.25 (-2.36%)

SIEGY Siemens
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

HSIC Henry Schein
$61.21 /

+0.48 (+0.79%)

ABT Abbott
$93.06 /

-2.25 (-2.36%)

ABT Abbott
$93.06 /

-2.25 (-2.36%)

Conference/Events
Henry Schein management to meet virtually with Oppenheimer » 04:55
05/20/20
05/20
04:55
05/20/20
04:55
HSIC

Henry Schein

$57.02 /

+0.58 (+1.03%)

Virtual Meeting to be…

Virtual Meeting to be held on May 20 hosted by Oppenheimer.

ShowHide Related Items >><<
HSIC Henry Schein
$57.02 /

+0.58 (+1.03%)

HSIC Henry Schein
$57.02 /

+0.58 (+1.03%)

05/06/20 Barrington
Henry Schein downgraded to Market Perform from Outperform at Barrington
04/07/20 Goldman Sachs
Henry Schein upgraded to Buy from Neutral at Goldman Sachs
04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
HSIC Henry Schein
$57.02 /

+0.58 (+1.03%)

HSIC Henry Schein
$57.02 /

+0.58 (+1.03%)

Conference/Events
Henry Schein management to meet virtually with Oppenheimer » 08:09
05/19/20
05/19
08:09
05/19/20
08:09
HSIC

Henry Schein

$56.44 /

+4.68 (+9.04%)

Virtual Meeting to be…

Virtual Meeting to be held on May 20 hosted by Oppenheimer.

ShowHide Related Items >><<
HSIC Henry Schein
$56.44 /

+4.68 (+9.04%)

HSIC Henry Schein
$56.44 /

+4.68 (+9.04%)

05/06/20 Barrington
Henry Schein downgraded to Market Perform from Outperform at Barrington
04/07/20 Goldman Sachs
Henry Schein upgraded to Buy from Neutral at Goldman Sachs
04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
HSIC Henry Schein
$56.44 /

+4.68 (+9.04%)

HSIC Henry Schein
$56.44 /

+4.68 (+9.04%)

Downgrade
Henry Schein downgraded to Market Perform from Outperform at Barrington » 08:43
05/06/20
05/06
08:43
05/06/20
08:43
HSIC

Henry Schein

$53.71 /

+1.11 (+2.11%)

Barrington analyst…

Barrington analyst Michael Petusky downgraded Henry Schein to Market Perform from Outperform without a price target following the company's Q1 results. A material recovery will take several quarters and there are easier ways to make a return in 2020 and 2021, Petusky tells investors in a research note. As such, the analyst will look for a better entry point into the shares.

ShowHide Related Items >><<
HSIC Henry Schein
$53.71 /

+1.11 (+2.11%)

04/07/20 Goldman Sachs
Henry Schein upgraded to Buy from Neutral at Goldman Sachs
04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
01/09/20 BofA
Henry Schein downgraded to Underperform from Neutral at BofA
Hot Stocks
Henry Schein sees restaurants competing for PPE supplies used by dental offices » 11:17
05/05/20
05/05
11:17
05/05/20
11:17
HSIC

Henry Schein

$52.34 /

-0.26 (-0.49%)

Henry Schein sees…

Henry Schein sees restaurants and other businesses open to public groups to have great demand for personal protective equipment products, such as gloves and masks, that are also used by dental and medical offices. While they will need different types of products, there will be competition for PPE products in general as businesses begin to reopen, company executives said during the Q&A portion of its earnings call.

ShowHide Related Items >><<
HSIC Henry Schein
$52.34 /

-0.26 (-0.49%)

04/07/20 Goldman Sachs
Henry Schein upgraded to Buy from Neutral at Goldman Sachs
04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
01/09/20 BofA
Henry Schein downgraded to Underperform from Neutral at BofA
Hot Stocks
Henry Schein sees Q2 cash flow 'negatively impacted' compared to Q1 » 11:11
05/05/20
05/05
11:11
05/05/20
11:11
HSIC

Henry Schein

$52.41 /

-0.19 (-0.36%)

Henry Schein is not…

Henry Schein is not giving specific cash flow guidance, other than to say the company "is well prepared" but that Q2 cash flow will be "negatively impacted" compared to Q1 due to sales declines forced by practice closures related to the COVID-19 pandemic.

ShowHide Related Items >><<
HSIC Henry Schein
$52.41 /

-0.19 (-0.36%)

04/07/20 Goldman Sachs
Henry Schein upgraded to Buy from Neutral at Goldman Sachs
04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
01/09/20 BofA
Henry Schein downgraded to Underperform from Neutral at BofA
Hot Stocks
Henry Schein says dental practice sales down 70%-80% quarter-to-date » 11:02
05/05/20
05/05
11:02
05/05/20
11:02
HSIC

Henry Schein

$52.57 /

-0.03 (-0.06%)

, PDCO

Patterson Companies

$16.37 /

+0.1 (+0.61%)

, XRAY

Dentsply Sirona

$40.35 /

+0.76 (+1.92%)

Henry Schein (HSIC)…

Henry Schein (HSIC) executives said dental practice sales have been down 70%-80% quarter-to-date. Henry Schein sees more consolidation as likely among U.S. dental practices in the wake of the COVID-19 crisis, continuing the trend of solo offices consolidating to mid-size and mid-sized practices consolidating into larger ones. Executives continue to speak on the company's earnings conference call. Patterson Companies (PDCO) and Dentsply Sirona (XRAY) are competing distributors in the dental supplies and equipment space.

ShowHide Related Items >><<
HSIC Henry Schein
$52.57 /

-0.03 (-0.06%)

04/07/20 Goldman Sachs
Henry Schein upgraded to Buy from Neutral at Goldman Sachs
04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
01/09/20 BofA
Henry Schein downgraded to Underperform from Neutral at BofA
PDCO Patterson Companies
$16.37 /

+0.1 (+0.61%)

04/02/20 Wolfe Research
Patterson Companies upgraded to Peer Perform from Underperform at Wolfe Research
02/28/20 JPMorgan
Patterson Companies upgraded to Neutral from Underweight at JPMorgan
02/27/20 BofA
BofA upgrades Patterson Companies to Buy after better than expected share gains
02/27/20 BofA
Patterson Companies upgraded to Buy from Neutral at BofA
XRAY Dentsply Sirona
$40.35 /

+0.76 (+1.92%)

04/24/20 H.C. Wainwright
Dentsply Sirona price target lowered to $38 from $51 at H.C. Wainwright
04/08/20 Baird
Dentsply Sirona upgraded to Outperform at Baird
04/08/20 Baird
Dentsply Sirona upgraded to Outperform from Neutral at Baird
04/07/20 Goldman Sachs
Dentsply Sirona downgraded to Neutral from Buy at Goldman Sachs
Hot Stocks
Henry Schein down fractionally as Q1 earnings call continues » 10:57
05/05/20
05/05
10:57
05/05/20
10:57
HSIC

Henry Schein

$52.73 /

+0.13 (+0.25%)

At time of writing,…

At time of writing, shares of Henry Schein are down 17c, or 0.3%, to $52.32 as the company's earnings conference call continues.

ShowHide Related Items >><<
HSIC Henry Schein
$52.73 /

+0.13 (+0.25%)

04/07/20 Goldman Sachs
Henry Schein upgraded to Buy from Neutral at Goldman Sachs
04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
01/09/20 BofA
Henry Schein downgraded to Underperform from Neutral at BofA
On The Fly
Fly Intel: Pre-market Movers » 09:08
05/05/20
05/05
09:08
05/05/20
09:08
ALXN

Alexion

$103.89 /

-0.07 (-0.07%)

, PTLA

Portola Pharmaceuticals

$7.76 /

+0.73 (+10.38%)

, TGTX

TG Therapeutics

$12.47 /

+1.22 (+10.84%)

, DD

DuPont

$44.67 /

-0.36 (-0.80%)

, SYY

Sysco

$53.84 /

+1.08 (+2.05%)

, MPC

Marathon Petroleum

$31.56 /

+2.31 (+7.90%)

, HSIC

Henry Schein

$52.60 /

+0.44 (+0.84%)

, IPGP

IPG Photonics

$118.77 /

-0.48 (-0.40%)

, USFD

US Foods

$19.94 /

+0.48 (+2.47%)

, SEE

Sealed Air

$27.23 /

-1 (-3.54%)

, ALK

Alaska Air

$28.69 /

-1.31 (-4.37%)

, W

Wayfair

$134.14 /

+11.49 (+9.37%)

, WRK

WestRock

$30.29 /

-0.57 (-1.85%)

, MNK

Mallinckrodt

$3.30 /

-0.055 (-1.64%)

, LITE

Lumentum

$78.44 /

+0.94 (+1.21%)

, HTZ

Hertz

$3.59 /

+0.085 (+2.43%)

, LB

L Brands

$12.05 /

+0.06 (+0.50%)

, KPTI

Karyopharm

$20.68 /

+1.35 (+6.98%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
ALXN Alexion
$103.89 /

-0.07 (-0.07%)

04/27/20 Cantor Fitzgerald
Alexion initiated with a Neutral at Cantor Fitzgerald
04/21/20 Baird
Alexion thesis unchanged following Ultomiris advance, says Baird
04/20/20 Morgan Stanley
Court claim construction largely favors Chugai over Alexion, says Morgan Stanley
03/17/20 Oppenheimer
Alexion downgraded to Perform at Oppenheimer
PTLA Portola Pharmaceuticals
$7.76 /

+0.73 (+10.38%)

04/23/20
Fly Intel: Top five analyst initiations
04/23/20 RBC Capital
Portola Pharmaceuticals initiated with an Outperform at RBC Capital
01/10/20 Cowen
Portola Pharmaceuticals price target lowered to $35 from $45 at Cowen
01/10/20 Oppenheimer
Oppenheimer downgrades Portola on Andexxa headwinds, cuts target to $17
TGTX TG Therapeutics
$12.47 /

+1.22 (+10.84%)

01/17/20 B. Riley FBR
TG Therapeutics price target raised to $25 from $17 at B. Riley FBR
01/17/20 H.C. Wainwright
TG Therapeutics price target raised to $24 from $20 at H.C. Wainwright
01/09/20 B. Riley FBR
Arbutus Biopharma price target raised to $6 from $3 at B. Riley FBR
12/09/19 B. Riley FBR
TG Therapeutics price target raised to $17 from $12 at B. Riley FBR
DD DuPont
$44.67 /

-0.36 (-0.80%)

04/29/20
Fly Intel: Top five analyst initiations
04/29/20 Wells Fargo
DuPont initiated with an Overweight at Wells Fargo
04/20/20
Fly Intel: Top five analyst upgrades
04/20/20 BMO Capital
DuPont price target lowered to $55 from $75 at BMO Capital
SYY Sysco
$53.84 /

+1.08 (+2.05%)

04/23/20
Fly Intel: Top five analyst downgrades
04/23/20 BMO Capital
Sysco downgraded to Market Perform from Outperform at BMO Capital
04/06/20 JPMorgan
Sysco price target lowered to $47 from $78 at JPMorgan
03/26/20
Fly Intel: Top five analyst upgrades
MPC Marathon Petroleum
$31.56 /

+2.31 (+7.90%)

04/24/20 Citi
Marathon Petroleum downgraded to Neutral from Buy at Citi
03/24/20 Raymond James
Marathon Petroleum double downgraded to Market Perform at Raymond James
03/24/20 Raymond James
Marathon Petroleum downgraded to Market Perform from Strong Buy at Raymond James
03/19/20 BofA
MPLX upgraded to Buy from Neutral at BofA
HSIC Henry Schein
$52.60 /

+0.44 (+0.84%)

04/07/20 Goldman Sachs
Henry Schein upgraded to Buy from Neutral at Goldman Sachs
04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
01/09/20 BofA
Henry Schein downgraded to Underperform from Neutral at BofA
IPGP IPG Photonics
$118.77 /

-0.48 (-0.40%)

02/14/20 DA Davidson
IPG Photonics price target raised to $170 from $150 at DA Davidson
02/13/20 Piper Sandler
IPG Photonics price target cut to $150 from $155 at Piper Sandler
01/29/20 Stifel
IPG Photonics downgraded to Hold from Buy at Stifel
12/20/19 Piper Sandler
IPG Photonics initiated with a Neutral at Piper Jaffray
USFD US Foods
$19.94 /

+0.48 (+2.47%)

04/27/20 Credit Suisse
US Foods price target lowered to $27 from $47 at Credit Suisse
04/23/20 BMO Capital
US Foods downgraded to Market Perform from Outperform at BMO Capital
04/06/20 JPMorgan
US Foods price target lowered to $24 from $45 at JPMorgan
03/17/20 Wells Fargo
US Foods covenant update not as bad as feared, says Wells Fargo
SEE Sealed Air
$27.23 /

-1 (-3.54%)

04/27/20
Fly Intel: Top five analyst downgrades
04/26/20 BMO Capital
Sealed Air downgraded to Market Perform from Outperform at BMO Capital
02/12/20 Baird
Sealed Air designated as Fresh Pick at Baird
12/19/19
Fly Intel: Top five analyst upgrades
ALK Alaska Air
$28.69 /

-1.31 (-4.37%)

05/04/20 Barclays
Barclays downgrades U.S. Airlines sector along with American and Delta
05/04/20 Barclays
Alaska Air price target lowered to $35 from $44 at Barclays
04/21/20 Deutsche Bank
Alaska Air price target lowered to $45 from $52 at Deutsche Bank
04/12/20
Airlines want Treasury to scrap proposal to make grant repayable, Reuters says
W Wayfair
$134.14 /

+11.49 (+9.37%)

05/04/20 Credit Suisse
Wayfair price target raised to $135 from $110 at Credit Suisse
05/04/20 Piper Sandler
Wayfair price target raised to $140 from $100 at Piper Sandler
05/01/20 Oppenheimer
Wayfair price target raised to $160 from $120 at Oppenheimer
04/29/20 Wedbush
Wayfair price target raised to $145 from $75 at Wedbush
WRK WestRock
$30.29 /

-0.57 (-1.85%)

04/09/20 KeyBanc
WestRock price target lowered to $27 from $34 at KeyBanc
04/07/20 Goldman Sachs
Goldman cuts paper and packaging estimates, prefers Ball and Graphic Packaging
02/28/20 Stephens
Paper companies should take 'closer look' at their dividends, says Stephens
02/13/20 BofA
Paused project a positive for containerboard market, says BofA
MNK Mallinckrodt
$3.30 /

-0.055 (-1.64%)

04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Mallinckrodt initiated with a Sell at Citi
02/25/20 Stifel
Mallinckrodt clearing path for shares to be revalued, says Stifel
01/22/20 Wells Fargo
Revance, Amphastar named top 2020 Specialty Pharmaceuticals ideas at Wells Fargo
LITE Lumentum
$78.44 /

+0.94 (+1.21%)

04/24/20 Rosenblatt
NeoPhotonics downgraded to Neutral at Rosenblatt with stock near three-year high
04/17/20 Goldman Sachs
Lumentum downgraded to Sell from Neutral at Goldman Sachs
03/27/20 Craig-Hallum
Lumentum price target lowered to $95 from $105 at Craig-Hallum
02/05/20 DA Davidson
Lumentum price target raised to $100 from $75 at DA Davidson
HTZ Hertz
$3.59 /

+0.085 (+2.43%)

04/27/20 Barclays
Barclays downgrades Hertz to Underweight on risk of capital call
04/27/20 Barclays
Hertz downgraded to Underweight from Equal Weight at Barclays
04/23/20 JPMorgan
JPMorgan sees rental cars as 'worst positioned,' cuts Hertz to Underweight
LB L Brands
$12.05 /

+0.06 (+0.50%)

05/05/20 Deutsche Bank
L Brands price target lowered to $16 from $24 at Deutsche Bank
05/05/20 BMO Capital
BMO upgrades L Brands after Sycamore deal ends, sees 50%-70% upside
05/05/20 BMO Capital
L Brands upgraded to Outperform from Market Perform at BMO Capital
04/24/20 Deutsche Bank
Deutsche reiterates Buy on L Brands, sees Sycamore deal closing
KPTI Karyopharm
$20.68 /

+1.35 (+6.98%)

04/07/20 Wedbush
Wedbush sees signs of 'potential utility' for Karyopharm's selinexor for COVID
04/07/20 H.C. Wainwright
XPO1 inhibitors have shown promise as COVID-19 treatment, says H.C. Wainwright
03/04/20 Barclays
Karyopharm initiated with an Overweight at Barclays
03/03/20 Canaccord
Karyopharm price target raised to $35 from $22 at Canaccord
Earnings
Henry Schein not providing FY20 guidance at this time » 07:13
05/05/20
05/05
07:13
05/05/20
07:13
HSIC

Henry Schein

$52.60 /

+0.44 (+0.84%)

Henry Schein's…

Henry Schein's financial guidance announced on February 20, specifically noted that guidance assumed no significant supply chain disruption related to COVID-19. On April 6, in light of the growing impact of COVID-19 on the business operations of the company and its customers, Henry Schein announced the withdrawal of its previously announced financial guidance for 2020. Due to the continued uncertainty surrounding COVID-19 and its impact to business operations, Henry Schein is not providing 2020 financial guidance at this time.

ShowHide Related Items >><<
HSIC Henry Schein
$52.60 /

+0.44 (+0.84%)

04/07/20 Goldman Sachs
Henry Schein upgraded to Buy from Neutral at Goldman Sachs
04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
01/09/20 BofA
Henry Schein downgraded to Underperform from Neutral at BofA

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.